Nav: Home

St. Gallen 2015: Latest multidisciplinary research in early breast cancer

March 31, 2015

The latest challenges of early breast cancer research include refining classification and predicting treatment responses, according to a report on the 14th St Gallen International Breast Cancer Consensus Conference, published in ecancermedicalscience.

The 2015 conference assembled nearly 3200 participants from 134 countries worldwide in Vienna, Austria to decide the consensus of breast cancer care and treatment.

Led by Dr Angela Esposito of the European Institute of Oncology, Milan, Italy, the report highlights some of the controversial areas discussed in this important meeting.

The highlight of the event is the St Gallen Consensus on the optimal treatment of early breast cancer.

The 2015 Consensus, delivered by about 45 of the world's most experienced opinion leaders in the field of breast cancer treatment, addressed some key areas of controversy, including the usefulness of existing breast cancer classification systems and the role of genetic variability.

The recommendations emerging from this panel will set the standard for breast cancer care for the next two years.

"This is the unique feature of the St. Gallen Consensus," writes Dr Giuseppe Curigliano, co-author, "ensuring that the resulting recommendations will take due cognizance of the variable resource limitations in different countries."
-end-
Reference:

Esposito A, Criscitiello C and Curigliano G (2015) Highlights from the 14th St Gallen International Breast Cancer Conference 2015 in Vienna: Dealing with classification, prognostication and prediction refinement to personalize the treatment of patients with early breast cancer ecancer 9 518

http://ecancer.org/journal/9/518.php

ecancermedicalscience is the open-access journal of the Organisation of European Cancer Institutes (OECI).

ecancermedicalscience

Related Breast Cancer Treatment Articles:

Breast cancer gene a potential target for childhood liver cancer treatment
Hepatoblastoma is a rare liver cancer that mainly affects infants and young children and is associated with mutations in the β-catenin gene.
Breast cancer can form 'sleeper cells' after drug treatment
Breast cancer medicines may force some cancer cells into 'sleeper mode,' allowing them to potentially come back to life years after initial treatment.
Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.
Research identifies new treatment targets in breast cancer
Scientists at Huntsman Cancer Institute (HCI) at the University of Utah (U of U), in collaboration with the Salk Institute for Biological Studies, have generated the first single cell resolution atlas of genes that control the formation of breast tissue.
New treatment for aggressive breast cancer
Approximately 10-15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur.
New focus on where heart disease and breast cancer treatment meet
The American Heart Association has released the first scientific statement about heart disease and breast cancer, calling for more research and collaboration between the fields of oncology and cardiology to treat and prevent both diseases.
Surgeons have major influence on breast cancer treatment
A woman's choice of surgeon plays a significant role in whether she's likely to receive contralateral prophylactic mastectomy, an increasingly popular aggressive breast cancer surgery.
Targeting 'Achilles' heel' could supercharge breast cancer treatment
A new class of anti-cancer agents targeting cancer cells' 'Achilles' heel' could help to supercharge breast cancer treatment, improving outcomes for the most aggressive types of breast cancer.
The way breast cancer genes act could predict your treatment
A Michigan State University breast cancer researcher has shown that effective treatment options can be predicted based on the way certain breast cancer genes act or express themselves.
IVF treatment not associated with increased risk of breast cancer
Among women undergoing fertility treatment in the Netherlands between 1980 and 1995, the use of in vitro fertilization compared with non-IVF treatment was not associated with increased risk of breast cancer after a median follow-up of 21 years, according to a study appearing in the July 19 issue of JAMA.
More Breast Cancer Treatment News and Breast Cancer Treatment Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.